Amgen (AMGN) Amortization - Intangibles (2009 - 2012)
Amgen (AMGN) posted Amortization - Intangibles of $73.0 million for Q4 2012, down 1.35% on a QoQ basis from $74.0 million in Q3 2012, and little changed year-over-year from $73.0 million in Q1 2012.
Analysis
Amgen (AMGN) Amortization - Intangibles (2009 - 2012) Analysis & Trends
Amgen has reported Amortization - Intangibles for 4 years, with the latest figure at $73.0 million in Q4 2012.
- On a quarterly basis, Amortization - Intangibles changed 0.0% year-over-year to $73.0 million in Q4 2012; TTM through Dec 2012 was $294.0 million, a 0.0% change from a year earlier, with the FY2012 full-year figure at $294.0 million, changed 0.0% from the prior year.
- Amortization - Intangibles was $73.0 million for Q4 2012 at Amgen, down from $74.0 million in the prior quarter.
- The five-year high for Amortization - Intangibles was $74.0 million in Q1 2009, with the low at $73.0 million in Q2 2009.
- Average Amortization - Intangibles over 4 years is $73.5 million, with a median of $73.5 million recorded in 2009.
- The largest YoY upside for Amortization - Intangibles was 0.0% in 2010 against a maximum downside of 0.0% in 2010.
- Over 4 years, Amortization - Intangibles stood at $73.0 million in 2009, then changed by 0.0% to $73.0 million in 2010, then changed by 0.0% to $73.0 million in 2011, then changed by 0.0% to $73.0 million in 2012.
- The last three Amortization - Intangibles figures came in at $73.0 million (Q4 2012), $74.0 million (Q3 2012), and $73.0 million (Q2 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Insmed | 28.06 Bn | 26.90 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 73.00 Mn |
| Sep 30, 2012 | 74.00 Mn |
| Jun 30, 2012 | 73.00 Mn |
| Mar 31, 2012 | 74.00 Mn |
| Dec 31, 2011 | 73.00 Mn |
| Sep 30, 2011 | 74.00 Mn |
| Jun 30, 2011 | 73.00 Mn |
| Mar 31, 2011 | 74.00 Mn |
| Dec 31, 2010 | 73.00 Mn |
| Sep 30, 2010 | 74.00 Mn |
| Jun 30, 2010 | 73.00 Mn |
| Mar 31, 2010 | 74.00 Mn |
| Dec 31, 2009 | 73.00 Mn |
| Sep 30, 2009 | 74.00 Mn |
| Jun 30, 2009 | 73.00 Mn |
| Mar 31, 2009 | 74.00 Mn |